Amplify Weight Loss Drug & Treatment ETF (THNR) Research
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
Market snapshot
- Symbol
- THNR
- Price
- $24.10
- Day change
- -0.67%
- Market cap
- $3.1M
- 52-week range
- 21.7-27.28
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- AdvisorShares Hotel ETF (BEDZ)
- City Different Investments Global Equity ETF (CDIG)
- Columbia Research Enhanced Real Estate ETF (CRED)
- Ocean Park International ETF (DUKX)
- Pacer Developed Markets Cash Cows Growth Leaders ETF (EAFG)
- AdvisorShares Restaurant ETF (EATZ)
- Genter Capital Dividend Income ETF (GEND)
- ProShares - S&P Global Core Battery Metals ETF (ION)
Open Amplify Weight Loss Drug & Treatment ETF (THNR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.